SCHEMBL4926907

SCHEMBL4926907

O=C(NO)C(Cc1ccc([N+](=O)[O-])cc1)NCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEP1B Q16820 2/20 0.58
ANPEP P15144 1/20 0.53
MMP1 P03956 1/20 0.52
FCER2 P06734 1/20 0.52
ITGA4 P13612 5/20 0.52
ITGB7 P26010 5/20 0.52
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
PSMB5 P28074 1/20 0.49
NPC1 O15118 1/20 0.49
TP53 P04637 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
PTPRF P10586 1/20 0.49
PTPN2 P17706 1/20 0.49
PTPN1 P18031 1/20 0.49
PTPN11 Q06124 1/20 0.49
MAPT P10636 1/20 0.47
MMP2 P08253 1/20 0.47
MMP9 P14780 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4926892 1.00 MEP1B (0.58) MEP1BANPEPMMP1FCER2ITGA4
SCHEMBL6797739 0.89 MMP1 (0.54) MEP1BMMP1FCER2ITGA4ITGB7
SCHEMBL6797746 0.89 MMP1 (0.54) MEP1BMMP1FCER2ITGA4ITGB7
SCHEMBL1096514 0.84 CA2 (0.55) ITGA4ITGB7MEN1KMT2ANPC1
SCHEMBL6801977 0.84 ITGA4 (0.59) ITGA4ITGB7MEN1KMT2ANPC1
SCHEMBL6806963 0.84 ITGA4 (0.59) ITGA4ITGB7MEN1KMT2ANPC1
SCHEMBL4934434 0.83 KMT2A (0.58) MEP1BMMP1FCER2ITGA4ITGB7
SCHEMBL4934416 0.83 KMT2A (0.58) MEP1BMMP1FCER2ITGA4ITGB7
SCHEMBL4930510 0.81 MMP1 (0.46) MMP1FCER2ITGA4ITGB7MEN1
SCHEMBL4930519 0.81 MMP1 (0.46) MMP1FCER2ITGA4ITGB7MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative KUREHA CORPORATION (JP) 2008-06-05 US disclosed
EP-1707560-A1 HYDROXAMIC ACID DERIVATIVE AND AGE GENERATION INHIBITOR CONTAINING THE DERIVATIVE Kureha Corporation (JP) 2006-10-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative HDAC5, HDAC1, HDAC9 MEP1B 651/4885ANPEP 848/4885MMP1 325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.